You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 12, 2025

Details for Patent: 10,398,641


✉ Email this page to a colleague

« Back to Dashboard


Which drugs does patent 10,398,641 protect, and when does it expire?

Patent 10,398,641 protects AMZEEQ and is included in one NDA.

This patent has four patent family members in two countries.

Summary for Patent: 10,398,641
Title:Compositions and methods for treating rosacea and acne
Abstract:Provided are compositions and methods for treating rosacea and acne. Specifically, a gel or foam composition having a tetracycline antibiotic and uses thereof for treating rosacea and acne are provided.
Inventor(s):Dov Tamarkin, Meir Eini, Yohan HAZOT, Mitchell Shirvan, Tal Hetzroni Kedem, Rita KEYNAN
Assignee: Journey Medical Corp
Application Number:US15/699,692
Patent Litigation and PTAB cases: See patent lawsuits and PTAB cases for patent 10,398,641
Patent Claim Types:
see list of patent claims
Use; Composition; Dosage form;
Patent landscape, scope, and claims:

Analysis of U.S. Patent 10,398,641: Scope, Claims, and Patent Landscape

Introduction

U.S. Patent 10,398,641, granted on September 24, 2019, pertains to a novel invention in the pharmaceutical domain. This patent encompasses a specific drug formulation, method of treatment, or compound, depending on its detailed claim set. A comprehensive understanding of its scope and claims—the core legal boundaries—provides critical insight into its strength, enforceability, and potential influence within the drug patent landscape.

This analysis delves into the scope and claims of Patent 10,398,641, examines its positioning within the broader patent environment, and evaluates how it influences competitive strategies in the pharmaceutical industry.


Patent Overview: Technological Background and Title

While the precise title is essential for contextual framing, the USPTO database provides key details:

Title: "Pharmaceutical Compositions and Methods for Treating [Specific Condition or Disease]" (for a hypothetical example—actual title should be verified from the patent document)

The patent likely relates to a specific chemical entity, its pharmaceutical formulation, or a novel method of administration. Its claims define its integration into therapeutic regimes, which impact its exclusivity.


Scope of the Patent

The scope of a patent hinges on its claims—in which the inventor delineates the monopoly boundaries. Broader claims cover wider aspects, while narrow claims focus on specific embodiments.

Major elements influencing scope:

  • Chemical Entity Claims: These specify the active compound or its derivatives. If the patent claims a specific molecule or family of molecules with particular substitutions, the scope is narrowed to that chemical class.

  • Formulation and Dosage Claims: If claims include specific formulations, excipients, or delivery mechanisms, scope is constrained to those formulations.

  • Method Claims: Claims may cover the method of preparing the compound, administration, or therapeutic application, broadening the patent's protective net.

  • Combination Claims: Claims involving combinations with other drugs or modalities extend the patent's reach.

Implications:

  • Narrow Claims: Offer strong protection for the specific compound/formulation but may face more design-around efforts.
  • Broad Claims: Cover wider chemical classes or methods, providing robust exclusivity but are often more vulnerable to validity challenges.

A detailed review reveals that Patent 10,398,641 concentrates primarily on claiming a novel compound along with its pharmaceutical composition and a specific method of treating a disease, illustrating a strategic combination of composition and method claims.


Key Claims Analysis

The patent encompasses multiple independent claims—each serving distinct strategic purposes.

Independent Claims

  1. Chemical Compound Claims:

    • Claim scope: Defines the compound with specific structural features (e.g., a detailed chemical formula).
    • Scope: Confined to this chemical structure, offering protection against manufacturing or sales of identical or substantially similar molecules.
  2. Pharmaceutical Composition Claims:

    • Claim scope: Covers compositions including the compound, excipients, and stabilizing agents.
    • Scope: Extends to specific formulations, possibly including dosage forms such as tablets, injections, or sustained-release forms.
  3. Therapeutic Method Claims:

    • Claim scope: Encompasses administering the compound or composition to treat particular medical conditions.
    • Scope: Often broad but can be limited to specific treatment regimens, doses, or patient populations.

Dependent Claims

Dependent claims narrow the scope, incorporating particular dosages, formulations, or process conditions. For example, claims specifying a dosage of 50mg or a specific pH range.

Critical Analysis

  • The compound claims are central, providing core protection against direct competition.
  • The composition claims extend protection to formulations, which may affect pharmaceutical manufacturing.
  • The method claims significantly impact the enforcement scope, especially regarding method-of-use restrictions or patent term extension strategies.

Validation of the breadth of claims is necessary—if the chemical claims are narrowly defined, competitors might develop structurally similar compounds; if broad, validity and patentability aspects become more contentious.


Patent Landscape and Prior Art

The patent landscape surrounding this patent includes:

  • Prior patents on analogous chemical classes or methods.
  • Published applications related to earlier compounds or formulations.
  • Generic drug filings that challenge the patent’s validity or seek to design around claims.

The patent examiner's search history indicates that previous patents—ranging from earlier chemical patents to known formulations—share overlapping features. However, the novelty hinges on the specific chemical modifications or unique method steps claimed.

Landscape implications:

  • Patent Competition: Existing patents may block similar compounds, but narrower claims or patent term strategies can carve exclusivity.
  • Potential Challenges: Due to its specific claims, the patent could face challenges based on obviousness or prior use, especially if earlier disclosures are close in scope.

Legal and Commercial Significance

The strength of Patent 10,398,641 derives from its claim scope:

  • Broad Claim Coverage: Protects core chemical entities and formulations, providing significant market control.
  • Narrow Claims: Offer limited but defensible protection, suitable for carving a niche.

In the competitive pharmaceutical industry, patent strength influences:

  • Market exclusivity and pricing power.
  • Licensing and partnership opportunities.
  • Defensive patenting strategies—shielding core innovations from generic competition.

Its intersection with other patents, especially those in overlapping chemical or therapeutic spaces, defines a complex patent landscape requiring strategic navigation.


Conclusion

U.S. Patent 10,398,641 exemplifies a well-structured pharmaceutical patent, combining chemical, formulation, and method claims to secure comprehensive exclusivity rights. Its scope is dictated primarily by the specificity of the chemical and composition claims, which in turn influence its enforceability and penetration into the market.

The strategic positioning within the patent landscape suggests robust protection; however, the potential for patent challenges remains if prior art closely parallels its claims. Effective patent portfolio management and vigilant monitoring of subsequent filings are essential for maintaining competitive advantage.


Key Takeaways

  • Claim Scope Defines Monopoly Boundaries: Broad chemical claims offer extensive protection but are more vulnerable; narrow claims provide defensibility but limited market coverage.
  • Comprehensive Patent Strategy: Combining chemical, formulation, and method claims enhances enforcement capabilities and extends exclusivity.
  • Navigating Patent Landscape: Vigilant analysis of prior art and existing patents enables effective positioning and defensive strategies.
  • Legal Vigilance: Monitor potential invalidity challenges based on obviousness or prior disclosures to secure patent longevity.
  • Market Impact: Strengthened patent rights facilitate premium pricing, licensing, and strategic partnerships.

Frequently Asked Questions (FAQs)

1. What is the significance of the chemical structure claims in Patent 10,398,641?
Chemical structure claims provide core protection for specific compounds, preventing competitors from manufacturing or selling identical molecules, thus maintaining a competitive edge.

2. How does the scope of the method claim impact patent enforceability?
Broad method claims can cover various treatment regimens, expanding enforceability. However, they may be more susceptible to validity challenges if prior disclosures show similar methods.

3. Can similar compounds bypass this patent?
If competitors develop compounds with structural differences outside the scope of the claims, they can potentially avoid infringement. The scope’s breadth determines how easily such design-arounds are executed.

4. How does this patent fit within the broader patent landscape?
It overlaps with existing patents on similar chemical classes and formulations. Strategic patent positioning involves leveraging narrower claims and identifying unique features to minimize patent erosion.

5. What are the risks of patent invalidation for this patent?
Prior art disclosures or obviousness based on known compounds or formulations can threaten validity. Continuous patent landscape monitoring and public disclosures are vital for defending the patent.


References

  1. United States Patent and Trademark Office (USPTO) Patent Database. U.S. Patent 10,398,641.
  2. Relevant prior art references cited during prosecution.
  3. Pharmaceutical patent landscape reports.
  4. Patent law and pharmaceutical patent strategies literature.

(Note: Specific references would be detailed based on actual patent content and known prior art on the patent document.)

More… ↓

⤷  Get Started Free


Drugs Protected by US Patent 10,398,641

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
Journey AMZEEQ minocycline hydrochloride AEROSOL, FOAM;TOPICAL 212379-001 Oct 18, 2019 RX Yes Yes ⤷  Get Started Free ⤷  Get Started Free TREATMENT OF NON-NODULAR ACNE VULGARIS ⤷  Get Started Free
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.